Invesco’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Invesco’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-172,158	Closed	-$1.42M	–	4122
2022 Q3	$1.42M	Buy	+172,158	New	+$1.32M	﹤0.01%	2783
2021 Q2	–	Sell	-13,985	Closed	-$102K	–	4125
2021 Q1	$102K	Sell	13,985 -2,525	-15%	-$21.8K	﹤0.01%	3757
2020 Q4	$95K	Buy	+16,510	New	+$94.5K	﹤0.01%	3650
2019 Q1	–	Sell	-2,678	Closed	-$43K	–	3906
2018 Q4	$43K	Sell	2,678 -12	-0.4%	-$264	﹤0.01%	3704
2018 Q3	$89K	Sell	2,690 -675	-20%	-$17.3K	﹤0.01%	3794
2018 Q2	$76K	Buy	+3,365	New	+$79.8K	﹤0.01%	3789
2014 Q1	–	Sell	-1,941	Closed	-$36K	–	4359
2013 Q4	$36K	Buy	1,941 +137	+8%	+$2.74K	﹤0.01%	4120
2013 Q3	$37K	Buy	1,804 +169	+10%	+$3.87K	﹤0.01%	4114
2013 Q2	$41K	Buy	+1,635	New	+$69.9K	﹤0.01%	4071

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Invesco's AVEO Position: Q4 2022 in Review

Invesco sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 172,158 shares — an estimated $1.42M sold.

Invesco first reported a position in AVEO in Q2 2013 and held it in 9 quarters. The position peaked at $1.42M in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Invesco reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Invesco sold 172,158 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1.42M.
Invesco first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 9 quarters.
Invesco's AVEO Pharmaceuticals, Inc. position peaked at $1.42M in Q3 2022.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.